Provided By GlobeNewswire
Last update: Mar 28, 2025
Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial
Results to Date Highlight TUS Potential as an Ideal Third Drug to Include in AML Triplet Therapy
Read more at globenewswire.com